ConductScience.org, home

Paper37077288

Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria.

Sagong HY and 8 others. Med Chem Res, 2022. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria. Papers, record 37077288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37077288

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria.
PubMed
Journal
Med Chem Res
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2023-04-24
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sagong HYHye Yeon
2Rosado-Lugo JDJesus D
3Bryan EJEric J
4Ferrer-González EEdgar
5Wang YYiling
6Cao YYanlu
7Parhi AKAjit K
8Pilch DSDaniel S
9LaVoie EJEdmond Jhttps://orcid.org/0000-0001-9244-1249

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI118874NIAID NIH HHSUnited StatesR01AI118874PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117644596A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.J Bacteriol2007https://conductscience.org/library/papers/17644596PubMed
217024474The prokaryotic cytoskeleton: a putative target for inhibitors and antibiotics?Appl Microbiol Biotechnol2006https://conductscience.org/library/papers/17024474PubMed
321823588Chemical-biological studies of subcellular organization in bacteria.Biochemistry2011https://conductscience.org/library/papers/21823588PubMed
421993484
In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
Int J Antimicrob Agents2012https://conductscience.org/library/papers/21993484PubMed
520381346Synthesis and evaluation of a series of C5'-substituted duocarmycin SA analogs.Bioorg Med Chem Lett2010https://conductscience.org/library/papers/20381346PubMed
617213642Structure-activity relationship study of the bacterial actin-like protein MreB inhibitors: effects of substitution of benzyl group in S-benzylisothiourea.Biosci Biotechnol Biochem2007https://conductscience.org/library/papers/17213642PubMed
720023035MreB drives de novo rod morphogenesis in Caulobacter crescentus via remodeling of the cell wall.J Bacteriol2010https://conductscience.org/library/papers/20023035PubMed
826548775Bacterial cytoskeleton and implications for new antibiotic targets.J Drug Target2016https://conductscience.org/library/papers/26548775PubMed
916391237Actin homolog MreB and RNA polymerase interact and are both required for chromosome segregation in Escherichia coli.Genes Dev2006https://conductscience.org/library/papers/16391237PubMed
1022154164MreB: pilot or passenger of cell wall synthesis?Trends Microbiol2012https://conductscience.org/library/papers/22154164PubMed
1127427089Antibacterial, cyto and genotoxic activities of A22 compound ((S-3, 4 -dichlorobenzyl) isothiourea hydrochloride).Microb Pathog2016https://conductscience.org/library/papers/27427089PubMed
1214982627MreB, the cell shape-determining bacterial actin homologue, co-ordinates cell wall morphogenesis in Caulobacter crescentus.Mol Microbiol2004https://conductscience.org/library/papers/14982627PubMed
1324603761The actin homologue MreB organizes the bacterial cell membrane.Nat Commun2014https://conductscience.org/library/papers/24603761PubMed
1423756461Direct interaction of FtsZ and MreB is required for septum synthesis and cell division in Escherichia coli.EMBO J2013https://conductscience.org/library/papers/23756461PubMed
1515564663Structure-activity relationship of S-benzylisothiourea derivatives to induce spherical cells in Escherichia coli.Biosci Biotechnol Biochem2004https://conductscience.org/library/papers/15564663PubMed
1635625337TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens.Antibiotics (Basel)2022https://conductscience.org/library/papers/35625337PubMed
1715016371Bacterial mitotic machineries.Cell2004https://conductscience.org/library/papers/15016371PubMed
1815707892MreB actin-mediated segregation of a specific region of a bacterial chromosome.Cell2005https://conductscience.org/library/papers/15707892PubMed
1925784047Bacterial actin and tubulin homologs in cell growth and division.Curr Biol2015https://conductscience.org/library/papers/25784047PubMed
2023473681Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA.Bioorg Med Chem Lett2013https://conductscience.org/library/papers/23473681PubMed

See all 24 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42889336Bacterial actin MreB as a new antibiotic target.Front Mol Biosci2026https://conductscience.org/library/papers/42889336PubMed
42859226Antibiotic-producing microorganisms: taxonomic diversity, screening strategies, and emerging and underexploited antibacterial targets.Arch Microbiol2026https://conductscience.org/library/papers/42859226PubMed
41900076Tetrahydrocarbazole as a Versatile Scaffold in Drug Discovery: A Cross-Target SAR Analysis and Design Paradigms.Molecules2026https://conductscience.org/library/papers/41900076PubMed
40847400MreB: unraveling the molecular mechanisms of bacterial shape, division, and environmental adaptation.Cell Commun Signal2025https://conductscience.org/library/papers/40847400PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37077288

GET https://conductscience.org/api/papers/v1/37077288/references?page=2